Pre-implantation Genetic Testing

Abnormal Embryo (46, XY, -16, +22)

Pre-implantation Genetic Testing of Embryo Biopsy is a screening test usually offered in association with treatment for the Assisted Reproductive Treatment (ART) to try to improve IVF success rate by selecting an Euploidy (chromosomally healthy) embryo for implantation.

Carriers of chromosome rearrangements, including Robertsonian and reciprocal translocations, deletions, duplications, insertions and inversions, can lead to an increased risk of producing aneuploid (chromosomally unhealthy) embryos and result in increased chance of implantation failure, miscarriage or, less commonly, liveborn children with physical and developmental disabilities.

Accurate risk assessment associated with the specific chromosome rearrangement is essential so that couples understand the risk of abnormality.

Both the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine now recommend universal PGT-A screening.

Speak to your IVF doctor for Preimplantation Genetic Testing.

GenomixLAB Offers

  • Preimplantation Genetic Testing – Monogenic (PGT-M) disorders
  • Preimplantation Genetic Testing – Structural Rearrangements (PGT-SR)
  • Preimplantation Genetic Testing  – HLA (Human Leucocyte Antigen) typing

Contact GenomixLAB for a Quotation

Download Preimplantation Genetic Test Requisition form